A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response

Infection and Immunity

Volumn 78, Issue 11, 2010, Pages 4734-4743

  Guglielmetti, Simone ^a   Taverniti, Valentina ^a   Minuzzo, Mario ^a   Arioli, Stefania ^a   Zanoni, Ivan ^b   Stuknyte, Milda ^a   Granucci, Francesca ^b   Karp, Matti ^c   Mora, Diego ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; ERYTHROMYCIN; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; KANAMYCIN; OXYTETRACYCLINE; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS COAGULANS; BACTERIUM ADHERENCE; BIFIDOBACTERIUM ANIMALIS; BONE MARROW CELL; CARCINOMA CELL; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DAIRY PRODUCT; DENDRITIC CELL; DOSE RESPONSE; GROUP A STREPTOCOCCAL INFECTION; HUMAN; HUMAN CELL; HYPOPHARYNX CARCINOMA; IMMUNE RESPONSE; IMMUNOREGULATION; IN VITRO STUDY; KERATINOCYTE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS HELVETICUS; LACTOBACILLUS RHAMNOSUS; LACTOCOCCUS LACTIS; PHARYNX; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS THERMOPHILUS; TH1 CELL;

ANTIBIOSIS; BACTERIAL ADHESION; CELL LINE; CYTOKINES; DAIRYING; EPITHELIAL CELLS; HUMANS; IMMUNOMODULATION; LACTOBACILLUS HELVETICUS; MUCOUS MEMBRANE; PHARYNX; PROBIOTICS; STREPTOCOCCUS PYOGENES;

EID: 78049450460     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00559-10     Document Type: Article

References (53)

1. Ahola, A. J., H. Yli-Knuuttila, T. Suomalainen, T. Poussa, A. Ahlstrom, J. H. Meurman, and R. Korpela. 2002. Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch. Oral Biol. 47:799-804.
2. Arioli, S., C. Monnet, S. Guglielmetti, C. Parini, I. De Noni, J. Hogenboom, P. M. Halami, and D. Mora. 2007. Aspartate biosynthesis is essential for the growth of Streptococcus thermophilus in milk, and aspartate availability modulates the level of urease activity. Appl. Environ. Microbiol. 73:5789-5796.
3. Arpinati, M., C. L. Green, S. Heimfeld, J. E. Heuser, and C. Anasetti. 2000. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95:2484-2490.
4. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290.
5. Bao, X. Q., and G. T. Liu. 2009. Induction of overexpression of the 27- and 70-kDa heat shock proteins by bicyclol attenuates concanavalin A-induced liver injury through suppression of nuclear factor-kappaB in mice. Mol. Pharmacol. 75:1180-1188.
6. Barton, B. E., and J. V. Jackson. 1993. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect. Immun. 61: 1496-1499.
7. Bernardeau, M., J. P. Vernoux, S. Henri-Dubernet, and M. Gueguen. 2008. Safety assessment of dairy microorganisms: the Lactobacillus genus. Int. J. Food Microbiol. 126:278-285.
8. Bisno, A. L. 1996. Acute pharyngitis: etiology and diagnosis. Pediatrics 97: 949-954.
9. Bonifait, L., F. Chandad, and D. Grenier. 2009. Probiotics for oral health: myth or reality? J. Can. Dent. Assoc. 75:585-590.
10. Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771.
11. Caglar, E., S. K. Cildir, S. Ergeneli, N. Sandalli, and S. Twetman. 2006. Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odontol. Scand. 64:314-318.
12. Clarke, J. O., and G. E. Mullin. 2008. A review of complementary and alternative approaches to immunomodulation. Nutr. Clin. Pract. 23:49-62.
13. Corr, S. C., C. Hill, and C. G. Gahan. 2009. Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Adv. Food Nutr. Res. 56:1-15.
14. Cosseau, C., D. A. Devine, E. Dullaghan, J. L. Gardy, A. Chikatamarla, S. Gellatly, L. L. Yu, J. Pistolic, R. Falsafi, J. Tagg, and R. E. Hancock. 2008. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect. Immun. 76:4163-4175.
15. EFSA. 2008. Update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance. Prepared by the Panel on Additives and Products or Substances used in Animal Feed. EFSA J. 732:1-15.
16. FAO/WHO. 2002. Report of a joint FAO/WHO expert consultation on guidelines for the evaluation of probiotics in food. World Health Organization and Food and Agriculture Organization of the United Nations, London, Ontario, Canada.
17. Galdeano, C. M., A. de Moreno de LeBlanc, G. Vinderola, M. E. Bonet, and G. Perdigon. 2007. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin. Vaccine Immunol. 14:485-492.
18. Granucci, F., C. Vizzardelli, N. Pavelka, S. Feau, M. Persico, E. Virzi, M. Rescigno, G. Moro, and P. Ricciardi-Castagnoli. 2001. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2:882-888.
19. Granucci, F., I. Zanoni, S. Feau, and P. Ricciardi-Castagnoli. 2003. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J. 22:2546-2551. (Pubitemid 36712352)
20. Granucci, F., I. Zanoni, and P. Ricciardi-Castagnoli. 2008. Central role of dendritic cells in the regulation and deregulation of immune responses. Cell. Mol. Life Sci. 65:1683-1697.
21. Guglielmetti, S., I. De Noni, F. Caracciolo, F. Molinari, C. Parini, and D. Mora. 2008. Bacterial cinnamoyl esterase activity screening for the production of a novel functional food product. Appl. Environ. Microbiol. 74:1284-1288.
22. Guglielmetti, S., I. Tamagnini, D. Mora, M. Minuzzo, A. Scarafoni, S. Arioli, J. Hellman, M. Karp, and C. Parini. 2008. Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Appl. Environ. Microbiol. 74:4695-4702.
23. Guglielmetti, S., V. Taverniti, M. Minuzzo, S. Arioli, M. Stuknyte, M. Karp, and D. Mora. 23 April 2010, posting date. Oral bacteria as potential probiotic for the pharyngeal mucosa. Appl. Environ. Microbiol. doi:10.1128/AEM.00109-10.
24. Horz, H. P., A. Meinelt, B. Houben, and G. Conrads. 2007. Distribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real-time quantitative polymerase chain reaction. Oral Microbiol. Immunol. 22:126-130.
25. Juntunen, M., P. V. Kirjavainen, A. C. Ouwehand, S. J. Salminen, and E. Isolauri. 2001. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin. Diagn. Lab. Immunol. 8:293-296.
26. Kaarniranta, K., M. Elo, R. Sironen, M. J. Lammi, M. B. Goldring, J. E. Eriksson, L. Sistonen, and H. J. Helminen. 1998. Hsp70 accumulation in chondrocytic cells exposed to high continuous hydrostatic pressure coincides with mRNA stabilization rather than transcriptional activation. Proc. Natl. Acad. Sci. U. S. A. 95:2319-2324.
27. Kahala, M., M. Maki, A. Lehtovaara, J. M. Tapanainen, R. Katiska, M. Juuruskorpi, J. Juhola, and V. Joutsjoki. 2008. Characterization of starter lactic acid bacteria from the Finnish fermented milk product viili. J. Appl. Microbiol. 105:1929-1938.
28. Kleerebezem, M., and E. E. Vaughan. 2009. Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu. Rev. Microbiol. 63:269-290.
29. Konstantinov, S. R., H. Smidt, W. M. de Vos, S. C. Bruijns, S. K. Singh, F. Valence, D. Molle, S. Lortal, E. Altermann, T. R. Klaenhammer, and Y. van Kooyk. 2008. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl. Acad. Sci. U. S. A. 105:19474-19479.
30. Kopp, E., and S. Ghosh. 1994. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265:956-959.
31. Krutmann, J. 2009. Pre- and probiotics for human skin. J. Dermatol. Sci. 54:1-5.
32. Laroia, G., R. Cuesta, G. Brewer, and R. J. Schneider. 1999. Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science 284: 499-502.
33. Lee, Y. K., K. Nomoto, S. Salminen, and S. L. Gorbach. 1999. Introduction, p. 24. In Handbook of probiotics. John Wiley & Sons, Inc., New York, NY.
34. Loimaranta, V., J. Tenovuo, L. Koivisto, and M. Karp. 1998. Generation of bioluminescent Streptococcus mutans and its usage in rapid analysis of the efficacy of antimicrobial compounds. Antimicrob. Agents Chemother. 42: 1906-1910.
35. Metchnikoff, E. 1907. The prolongation of life. Optimistic studies. Translated and edited by P. Chalmers Mitchell. Heinemann, London, United Kingdom.
36. Moon, R., T. A. Pritts, A. A. Parikh, J. E. Fischer, A. L. Salzman, M. Ryan, H. R. Wong, and P. O. Hasselgren. 1999. Stress response decreases the interleukin-1beta-induced production of complement component C3 in human intestinal epithelial cells. Clin. Sci. (London) 97:331-337.
37. Moser, C., P. O. Jensen, T. Pressler, B. Frederiksen, S. Lanng, A. Kharazmi, C. Koch, and N. Hoiby. 2005. Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. APMIS 113:400-409.
38. Papanicolaou, D. A., R. L. Wilder, S. C. Manolagas, and G. P. Chrousos. 1998. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128:127-137.
39. Parikh, A. A., M. R. Moon, C. D. Kane, A. L. Salzman, J. E. Fischer, and P. O. Hasselgren. 1998. Interleukin-6 production in human intestinal epithelial cells increases in association with the heat shock response. J. Surg. Res. 77:40-44.
40. Piana, C., M. Wirth, S. Gerbes, H. Viernstein, F. Gabor, and S. Toegel. 2008. Validation of reference genes for qPCR studies on Caco-2 cell differentiation. Eur. J. Pharm. Biopharm. 69:1187-1192.
41. Pritts, T. A., E. S. Hungness, D. D. Hershko, B. W. Robb, X. Sun, G. J. Luo, J. E. Fischer, H. R. Wong, and P. O. Hasselgren. 2002. Proteasome inhibitors induce heat shock response and increase IL-6 expression in human intestinal epithelial cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:R1016-R1026.
42. Reid, G., J. Dols, and W. Miller. 2009. Targeting the vaginal microbiota with probiotics as a means to counteract infections. Curr. Opin. Clin. Nutr. Metab. Care 12:583-587.
43. Reilly, N., V. Poylin, M. Menconi, A. Onderdonk, S. Bengmark, and P. O. Hasselgren. 2007. Probiotics potentiate IL-6 production in IL-1beta-treated Caco-2 cells through a heat shock-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293:R1169-R1179.
44. Rissoan, M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, M. R. de Waal, and Y. J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183-1186.
45. Shanley, T. P., J. L. Foreback, D. G. Remick, T. R. Ulich, S. L. Kunkel, and P. A. Ward. 1997. Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury. Am. J. Pathol. 151:193-203.
46. Sokol, H., B. Pigneur, L. Watterlot, O. Lakhdari, L. G. Bermudez-Humaran, J. J. Gratadoux, S. Blugeon, C. Bridonneau, J. P. Furet, G. Corthier, C. Grangette, N. Vasquez, P. Pochart, G. Trugnan, G. Thomas, H. M. Blottiere, J. Dore, P. Marteau, P. Seksik, and P. Langella. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U. S. A. 105:16731-16736.
47. Tagg, J., P. Wescombe, and J. Burton. 2006. Oral streptococcal BLIS: heterogeneity of the effector molecules and potential role in the prevention of streptococcal infections. Int. Congr. Ser. 1289:347-350.
48. Theodorakis, N. G., and R. I. Morimoto. 1987. Posttranscriptional regulation of hsp70 expression in human cells: effects of heat shock, inhibition of protein synthesis, and adenovirus infection on translation and mRNA stability. Mol. Cell. Biol. 7:4357-4368.
49. Wagenvoort, J. H., R. J. Penders, B. I. Davies, and R. Lutticken. 2005. Similar environmental survival patterns of Streptococcus pyogenes strains of different epidemiologic backgrounds and clinical severity. Eur. J. Clin. Microbiol. Infect. Dis. 24:65-67.
50. Xing, Z., J. Gauldie, G. Cox, H. Baumann, M. Jordana, X. F. Lei, and M. K. Achong. 1998. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101:311-320.
51. Yamamoto, Y., and R. B. Gaynor. 2001. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107:135-142.
52. Zanoni, I., M. Foti, P. Ricciardi-Castagnoli, and F. Granucci. 2005. TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells. J. Immunol. 175:286-292.
53. Zeuthen, L. H., H. R. Christensen, and H. Frokiaer. 2006. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin. Vaccine Immunol. 13:365-375.